Liang Su - Nanhua Bio Secretary Board

000504 Stock   10.19  0.36  3.41%   

Executive

Liang Su is Secretary Board of Nanhua Bio Medicine
Age 44
Address Lugu Science and Technology, Changsha, China, 410205
Phone86 73 1858 10285
Webhttps://www.landfar.cn

Nanhua Bio Management Efficiency

The company has return on total asset (ROA) of (0.0455) % which means that it has lost $0.0455 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.313) %, meaning that it generated substantial loss on money invested by shareholders. Nanhua Bio's management efficiency ratios could be used to measure how well Nanhua Bio manages its routine affairs as well as how well it operates its assets and liabilities. At present, Nanhua Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 140.9 M, whereas Other Current Assets are forecasted to decline to about 6.9 M.

Similar Executives

Showing other executives

EXECUTIVE Age

Kai GuoShanghai Zhangjiang Hi Tech
44
Chaofeng GuLoctek Ergonomic Technology
46
Jian ZhangHunan Nanling Industrial
52
Chi WongHunan Nanling Industrial
52
Hai ZhouShandong Ruifeng Chemical
48
Feng CaiHunan Nanling Industrial
53
An DengHunan Nanling Industrial
58
Mi BaiLoctek Ergonomic Technology
N/A
Yuzhen HuLoctek Ergonomic Technology
39
Ying LuShanghai Zhangjiang Hi Tech
51
Yi JiangLoctek Ergonomic Technology
50
Haiguang SunLoctek Ergonomic Technology
48
Dongdong WangMing Yang Smart
43
Gang ZhengShanghai Zhangjiang Hi Tech
50
Yueling XuShandong Ruifeng Chemical
52
Zhai YongjunMing Yang Smart
46
Ziyang ZhaoShandong Ruifeng Chemical
37
Gang LiuHunan Nanling Industrial
44
Zhihui MeiLoctek Ergonomic Technology
46
Yongle PanMing Yang Smart
40
Jun HuangShanghai Zhangjiang Hi Tech
50
Nanhua Bio Medicine (000504) is traded on Shenzhen Stock Exchange in China and employs 5 people. Nanhua Bio is listed under Publishing category by Fama And French industry classification.

Management Performance

Nanhua Bio Medicine Leadership Team

Elected by the shareholders, the Nanhua Bio's board of directors comprises two types of representatives: Nanhua Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanhua. The board's role is to monitor Nanhua Bio's management team and ensure that shareholders' interests are well served. Nanhua Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanhua Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Changqiao You, GM Director
Pengbin Lin, Deputy CFO
Ailong Liu, Deputy Manager
Liang Su, Secretary Board
Yong Chen, Deputy Manager

Nanhua Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nanhua Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nanhua Stock

Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.